Article Text

Download PDFPDF
Duodenal adenomatosis in familial adenomatous polyposis
  1. S Bülow1,
  2. J Björk2,
  3. I J Christensen3,
  4. O Fausa4,
  5. H Järvinen5,
  6. F Moesgaard1,
  7. H F A Vasen6,
  8. the DAF Study Group
  1. 1The Danish Polyposis Register, Hvidovre University Hospital, Copenhagen, Denmark
  2. 2The Swedish Polyposis Register, Karolinska Sjukhuset, Stockholm, Sweden
  3. 3The Finsen Laboratory, Copenhagen, Denmark
  4. 4The Norwegian Polyposis Register, Rikshospitalet, Oslo, Norway
  5. 5The Finnish Polyposis Register, Helsinki University Central Hospital, Helsinki, Finland
  6. 6The Dutch Polyposis Register, The Netherlands Foundation for the Detection of Hereditary Tumours, Leiden, the Netherlands
  1. Correspondence to:
    Dr S Bülow
    The Danish Polyposis Register, Hvidovre University Hospital, DK 2650 Hvidovre, Denmark; sbulowdadlnet.dk

Abstract

Background: The prevalence of duodenal carcinoma is much higher in familial adenomatous polyposis (FAP) than in the background population, and duodenal adenomatosis is found in most polyposis patients.

Aims: To describe the long term natural history of duodenal adenomatosis in FAP and evaluate if cancer prophylactic surveillance of the duodenum is indicated.

Methods: A prospective five nation study was carried out in the Nordic countries and the Netherlands.

Patients: A total of 368 patients were examined by gastroduodenoscopy at two year intervals during the period 1990–2001.

Results: At the first endoscopy, 238 (65%) patients had duodenal adenomas at a median age of 38 years. Median follow up was 7.6 years. The cumulative incidence of adenomatosis at age 70 years was 90% (95% confidence interval (CI) 79–100%), and of Spigelman stage IV 52% (95% CI 28–76%). The probability of an advanced Spigelman score increased during the study period (p<0.0001) due to an increasing number and size of adenomas. Two patients had asymptomatic duodenal carcinoma at their first endoscopy while four developed carcinoma during the study at a median age of 52 years (range 26–58). The cumulative incidence rate of cancer was 4.5% at age 57 years (95% CI 0.1–8.9%) and the risk was higher in patients with Spigelman stage IV at their first endoscopy than in those with stages 0–III (p<0.01).

Conclusions: The natural course of duodenal adenomatosis has now been described in detail. The high incidence and increasing severity of duodenal adenomatosis with age justifies prophylactic examination, and a programme is presented for upper gastrointestinal endoscopic surveillance.

  • familial adenomatous polyposis
  • duodenal adenomatosis
  • duodenal carcinoma
  • FAP, familial adenomatous polyposis
  • HR, hazard ratio

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles